Cargando…
The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients
A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) causing lethal acute respiratory disease emerged in December 2019. The World Health Organization named this disease “COVID-19” and declared it a pandemic on March 11, 2020. Many studies have shown that mesenchymal stem cells (MSCs) a...
Autores principales: | Alzahrani, Faisal A., Saadeldin, Islam M., Ahmad, Abrar, Kumar, Dipak, Azhar, Esam I., Siddiqui, Arif Jamal, Kurdi, Bassem, Sajini, Abdulrahim, Alrefaei, Abdulmajeed F., Jahan, Sadaf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512102/ https://www.ncbi.nlm.nih.gov/pubmed/33014070 http://dx.doi.org/10.1155/2020/8835986 |
Ejemplares similares
-
Mesenchymal Stem Cell Exosomes as Immunomodulatory Therapy for Corneal Scarring
por: Ong, Hon Shing, et al.
Publicado: (2023) -
Immunomodulatory Potential of Human Mesenchymal Stem Cells and their Exosomes on Multiple Sclerosis
por: Baharlooi, Hussein, et al.
Publicado: (2022) -
Exosomes as a Potential Tool for Supporting Canine Oocyte Development
por: Lee, Seok Hee, et al.
Publicado: (2020) -
Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19
por: Kumar, Dipak, et al.
Publicado: (2021) -
Mesenchymal Stem/Stromal Cell-Derived Exosomes for Immunomodulatory Therapeutics and Skin Regeneration
por: Ha, Dae Hyun, et al.
Publicado: (2020)